BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36147627)

  • 1. Detection of stage I HPV-driven oropharyngeal cancer in asymptomatic individuals in the Hamburg City Health Study using HPV16 E6 serology - A proof-of-concept study.
    Busch CJ; Hoffmann AS; Viarisio D; Becker BT; Rieckmann T; Betz C; Bender N; Schroeder L; Hussein Y; Petersen E; Jagodzinski A; Schäfer I; Burandt E; Lang Kuhs K; Pawlita M; Waterboer T; Brenner N
    EClinicalMedicine; 2022 Nov; 53():101659. PubMed ID: 36147627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence.
    Lang Kuhs KA; Kreimer AR; Trivedi S; Holzinger D; Pawlita M; Pfeiffer RM; Gibson SP; Schmitt NC; Hildesheim A; Waterboer T; Ferris RL
    Cancer; 2017 Nov; 123(22):4382-4390. PubMed ID: 28950407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of the Human Papillomavirus Type 16 E6 Antibody Response Prior to Oropharyngeal Cancer.
    Kreimer AR; Johansson M; Yanik EL; Katki HA; Check DP; Lang Kuhs KA; Willhauck-Fleckenstein M; Holzinger D; Hildesheim A; Pfeiffer R; Williams C; Freedman ND; Huang WY; Purdue MP; Michel A; Pawlita M; Brennan P; Waterboer T
    J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 28376197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of human papillomavirus antibodies in individuals with head and neck cancer.
    Lang Kuhs KA; Pawlita M; Gibson SP; Schmitt NC; Trivedi S; Argiris A; Kreimer AR; Ferris RL; Waterboer T
    Cancer Epidemiol; 2016 Jun; 42():46-52. PubMed ID: 27010729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absolute Risk of Oropharyngeal Cancer After an HPV16-E6 Serology Test and Potential Implications for Screening: Results From the Human Papillomavirus Cancer Cohort Consortium.
    Robbins HA; Ferreiro-Iglesias A; Waterboer T; Brenner N; Nygard M; Bender N; Schroeder L; Hildesheim A; Pawlita M; D'Souza G; Visvanathan K; Langseth H; Schlecht NF; Tinker LF; Agalliu I; Wassertheil-Smoller S; Ness-Jensen E; Hveem K; Grioni S; Kaaks R; Sánchez MJ; Weiderpass E; Giles GG; Milne RL; Cai Q; Blot WJ; Zheng W; Weinstein SJ; Albanes D; Huang WY; Freedman ND; Kreimer AR; Johansson M; Brennan P
    J Clin Oncol; 2022 Nov; 40(31):3613-3622. PubMed ID: 35700419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus (HPV) 16 antibodies at diagnosis of HPV-related oropharyngeal cancer and antibody trajectories after treatment.
    Zhang Y; Waterboer T; Haddad RI; Miles BA; Wentz A; Gross ND; Fakhry C; Quon H; Lorch JH; Gourin CG; Clayburgh D; Misiukiewicz KJ; Richmon JD; Andersen PE; Posner MR; D'Souza G
    Oral Oncol; 2017 Apr; 67():77-82. PubMed ID: 28351584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of human papillomavirus (HPV) 16 E6 seropositive individuals without HPV-associated malignancies after 10 years of follow-up in the UK Biobank.
    Brenner N; Mentzer AJ; Hill M; Almond R; Allen N; Pawlita M; Waterboer T
    EBioMedicine; 2020 Dec; 62():103123. PubMed ID: 33248371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity and Specificity of Human Papillomavirus (HPV) 16 Early Antigen Serology for HPV-Driven Oropharyngeal Cancer: A Systematic Literature Review and Meta-Analysis.
    Hibbert J; Halec G; Baaken D; Waterboer T; Brenner N
    Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34208476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV16 antibodies as risk factors for oropharyngeal cancer and their association with tumor HPV and smoking status.
    Anderson KS; Dahlstrom KR; Cheng JN; Alam R; Li G; Wei Q; Gross ND; Chowell D; Posner M; Sturgis EM
    Oral Oncol; 2015 Jul; 51(7):662-7. PubMed ID: 25957822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma.
    Holzinger D; Wichmann G; Baboci L; Michel A; Höfler D; Wiesenfarth M; Schroeder L; Boscolo-Rizzo P; Herold-Mende C; Dyckhoff G; Boehm A; Del Mistro A; Bosch FX; Dietz A; Pawlita M; Waterboer T
    Int J Cancer; 2017 Jun; 140(12):2748-2757. PubMed ID: 28316084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Antibodies to HPV16 Early Proteins Warrant Investigation as Potential Biomarkers for Risk Stratification and Recurrence of HPV-Associated Oropharyngeal Cancer.
    Fakhry C; Qualliotine JR; Zhang Z; Agrawal N; Gaykalova DA; Bishop JA; Subramaniam RM; Koch WM; Chung CH; Eisele DW; Califano J; Viscidi RP
    Cancer Prev Res (Phila); 2016 Feb; 9(2):135-41. PubMed ID: 26701665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Papillomavirus (HPV) 16 E6 seropositivity is elevated in subjects with oral HPV16 infection.
    Zhang Y; Waterboer T; Pawlita M; Sugar E; Minkoff H; Cranston RD; Wiley D; Burk R; Reddy S; Margolick J; Strickler H; Weber K; Gillison M; D'Souza G
    Cancer Epidemiol; 2016 Aug; 43():30-4. PubMed ID: 27344614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic accuracy of HPV16 early antigen serology for HPV-driven oropharyngeal cancer is independent of age and sex.
    Kusters JMA; Diergaarde B; Ness A; Schim van der Loeff MF; Heijne JCM; Schroeder L; Hueniken K; McKay JD; Macfarlane GJ; Lagiou P; Lagiou A; Polesel J; Agudo A; Alemany L; Ahrens W; Healy CM; Conway DI; Robinson M; Canova C; Holcátová I; Richiardi L; Znaor A; Pring M; Thomas S; Hayes DN; Liu G; Hung RJ; Brennan P; Olshan AF; Virani S; Waterboer T
    Int J Cancer; 2024 Jan; 154(2):389-402. PubMed ID: 37694289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcervical sonography and human papillomavirus 16 E6 antibodies are sensitive for the detection of oropharyngeal cancer.
    Lang Kuhs KA; Wood CB; Wiggleton J; Aulino JM; Latimer B; Smith DK; Bender N; Rohde S; Mannion K; Kim Y; Sinard R; Langerman A; Fleischer A; Fakhry C; Waterboer T; Netterville JL
    Cancer; 2020 Jun; 126(11):2658-2665. PubMed ID: 32129894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the Utility and Prevalence of HPV Biomarkers in Oral Rinses and Serology for HPV-related Oropharyngeal Cancer.
    D'Souza G; Clemens G; Troy T; Castillo RG; Struijk L; Waterboer T; Bender N; Pierorazio PM; Best SR; Strickler H; Wiley DJ; Haddad RI; Posner M; Fakhry C
    Cancer Prev Res (Phila); 2019 Oct; 12(10):689-700. PubMed ID: 31420362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum antibodies to the HPV16 proteome as biomarkers for head and neck cancer.
    Anderson KS; Wong J; D'Souza G; Riemer AB; Lorch J; Haddad R; Pai SI; Longtine J; McClean M; LaBaer J; Kelsey KT; Posner M
    Br J Cancer; 2011 Jun; 104(12):1896-905. PubMed ID: 21654689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus-Related Oropharyngeal Carcinoma.
    Rettig EM; Wentz A; Posner MR; Gross ND; Haddad RI; Gillison ML; Fakhry C; Quon H; Sikora AG; Stott WJ; Lorch JH; Gourin CG; Guo Y; Xiao W; Miles BA; Richmon JD; Andersen PE; Misiukiewicz KJ; Chung CH; Gerber JE; Rajan SD; D'Souza G
    JAMA Oncol; 2015 Oct; 1(7):907-15. PubMed ID: 26226294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGFR Protein Expression Relates with Tumor Histology, Methylation Status of EGFR and HPV16 E6 Viral Load in Oropharyngeal Carcinoma.
    Suzuki Y; Fukumura Y; Asahina M; Fujimaki M; Ohba S; Matsumoto F; Kurahayashi I; Yao T; Ikeda K
    Head Neck Pathol; 2021 Sep; 15(3):743-756. PubMed ID: 33428063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concordance of p16
    Mena M; Wang X; Tous S; Quiros B; Clavero O; Alejo M; Morey F; Taberna M; Leon Vintro X; Lloveras Rubio B; Alos L; Mehanna H; Quint W; Pawlita M; Tommasino M; Pavón MA; Muñoz N; De Sanjose S; Bosch FX; Alemany L; On Behalf Of The Ico International Hpv In Head And Neck Cancer Study Group
    Cancers (Basel); 2022 Aug; 14(15):. PubMed ID: 35954451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival advantage in patients with human papillomavirus-driven oropharyngeal cancer and variation by demographic characteristics and serologic response: Findings from Head and Neck 5000.
    Whitmarsh A; Pring M; Thomas SJ; Waylen A; Ness AR; Dudding T; Pawlita M; Brenner N; Waterboer T; Schroeder L
    Cancer; 2021 Jul; 127(14):2442-2452. PubMed ID: 33721332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.